Presentation of the research findings follows the process pathways laid out in the programme theory (Fig. 1) and is divided into Carroll et al’s main dimensions of programme implementation fidelity evaluation [37]: For each step in the pathway we present quantitative and qualitative results in an integrated, complementary way. All data describing the social-demographic and health profile and implementation integrity of MYICN interventions were summarised using descriptive statistics and these are presented in Tables 1-3.
Social demographic characteristics of the questionnaire respondents
In total, 188 women participated in the survey of which 54% were pregnant and 46% were postnatal mothers. The age of the respondents ranged from 15-55 years with a mean age of 25.5 years old and the majority (85%) were married with multigravida (62%). Almost half (44%) of these women had primary education and three quarters (75%) worked in informal sectors either as farmers, housewives or small-scale entrepreneurs. 14% of the respondents were students either at secondary or post-secondary levels. Out of those women who were tested for Haemoglobin at the health facilities as recorded in their clinic appointment cards, 27% were anaemic (<11g/dl) and the mean HB status was 9.97g/dl. These findings are presented in Table 1.
Table 1 Demographic and health profile of the respondents:
Indicator
|
Characteristics of women
|
Distribution (n)
|
Percentage (%)
|
Mean
|
|
Selected demographic characteristics of the respondents (n=188)
|
Maternal status
|
|
|
|
Pregnant
|
102
|
54
|
|
Recently delivered (RDM)
|
86
|
46
|
|
Age of the respondent (years)
|
|
|
|
15-19
|
15
|
8
|
|
20-24
|
79
|
42
|
|
25-29
|
59
|
31
|
|
30-34
|
22
|
12
|
|
35-39
|
10
|
16.5
|
|
≥40
|
3
|
2
|
|
Mean age
|
|
|
25.5
|
|
Educational level
|
|
|
|
Primary
|
82
|
44
|
|
Secondary
|
75
|
40
|
|
Post-secondary
|
31
|
16
|
|
|
Occupation
|
Farmer
|
74
|
39
|
|
Housewife
|
24
|
13
|
|
Casual labourer
|
6
|
3
|
|
Business
|
44
|
23
|
|
Student
|
27
|
14
|
|
Salaried
|
13
|
7
|
|
|
Marital status
|
Never married
|
28
|
15
|
|
Married
|
160
|
85
|
|
|
Gravida
|
Primigravida
|
72
|
38
|
|
Multigravida
|
116
|
62
|
|
|
Prevalence of anaemia among the participants(n=188)
|
HB examination (n=186)
Not tested for HB
|
26
|
14
|
|
Tested for HB
|
162
|
86
|
|
Mean haemoglobin (n=162)
concentration (g/dl*)
|
|
|
|
Severe anaemia (<8)
|
6
|
4
|
|
Moderate anaemia (8-9.99)
|
16
|
10
|
|
Mild anaemia (10-10.99)
|
22
|
13
|
|
≥11
|
118
|
73
|
|
|
|
|
|
|
*Grams per decilitre
Implementation fidelity of MYICN
In line with the implementation fidelity framework, we first present components related to adherence to an intervention followed by moderating variables which covered quality of delivery and participant responsiveness.
Adherence
The first component in Carroll et al’s framework of implementation fidelity is adherence to the intervention; implementation coverage, content and frequency of counselling and IFAs with the exclusion of duration are presented in Table 2 and elaborated below.
Coverage
Coverage for this study was based on the population covered by the intervention. As per the MYICN programme requirements, the intervention should cover all pregnant women across the country irrespective of their nutritional status. However, since the MYICN programme is implemented as an ANC integrated programme in government health facilities; it is only accessed by those women who seek routine Antenatal Care (ANC) services in these facilities. In this study, all respondents except two (RDM) had accessed ANC services at some point during their pregnancy period (which is not surprising since we recruited women at health facilities). However, as per findings of this study, only 10% of the respondents (intervention recipients) accessed ANC services during their first trimester of pregnancy, a majority attended after five or six months. Furthermore, not all women who had accessed health facilities for ANC were provided with the interventions recommended by the IFAs policy, thereby considerably reducing intervention coverage. Details are illustrated in the “content and frequency” section below.
Content and frequency
Regarding content we assessed the actual interventions received by these women based on MIYCN guidelines requirements: (1) general nutritional counselling, (2) issuing IFAs. With respect to frequency, we assessed the total number of times these women turned up for interventions at the health facility during their entire current gestation period and received the stated interventions.
The general nutritional counselling intervention received least attention by programme implementers. Only 28% of the respondents of the questionnaire reported to have received nutritional counselling on a general diet.
“I was not given any nutritional advice so I assumed my health condition was good. You know if blood is not enough or they notice that your health is not good they will advise you on what to eat.” (R31)
Long queues and staff shortages were the main reasons given by both programme implementers and intervention recipients for not providing or receiving nutritional counselling to all women:
“On that day the queue was too long. So I was not given any nutritional counselling.” (R18)
“We only provide nutritional counselling to those women who raise a nutritional concern or whose health is generally not good. Maybe their weight or HB is not adequate. Those who are HIV positive we refer them to AMPATH (Academic Model Providing Access to Healthcare) nutritionist for counselling. You cannot manage to provide individual counselling to everyone because they are too many and here you are providing so many services alone.” (Nursing officer attending to women at the MCH)
Women reported to have mainly acquired nutritional knowledge from other sources, including local women relations, school and own experience.
IFAs provision was clearly the main focus of MIYCN interventions. The IFAs interventions as a part of ANC were reported in at least 70% of women availing ANC (Table 2). The highest was iron supplementation (74%) and information on its usefulness (55%). The other elements of the interventions were reported by less than half of the questionnaire respondents.
Table 2. Content and frequency
|
Characteristics of women
|
Distribution (n)
|
Percentage (%)
|
|
|
Interventions received: (n=186)
|
Supplements received
|
Received Iron
|
138
|
74
|
|
Received folic acids
|
88
|
47
|
|
Counselling received
|
|
|
|
General nutrition information (n=186)
|
52
|
28
|
|
Information on iron (n=138)
|
76
|
55
|
|
Information on folic acid (n=88)
|
38
|
43
|
|
|
Total folic acid supplement pills received for the entire period of pregnancy (based on RDM*) (n-86)
|
Never Received any
|
9
|
11
|
<15
|
3
|
3
|
30
|
35
|
42
|
60
|
22
|
26
|
90
|
13
|
15
|
>90
|
3
|
3
|
|
Total iron pills received for the entire period of pregnancy (based on RDM*) (n-86)
|
Never received any
|
4
|
5
|
<15
|
13
|
15
|
30
|
41
|
49
|
60
|
12
|
14
|
90
|
9
|
10
|
150
|
6
|
7
|
|
*Recently Delivered Mothers
Pregnant women are supposed to be encouraged to take IFAs daily during the duration of pregnancy irrespective of their haemoglobin levels (60mg of iron and 400 μg folic acid per day) to prevent anaemia, receiving a minimum of 120 pills of iron and 120 pills of folic acid (four months’ supply). However, only 3% and 17% of the respondents received more than 90 pills of folic acid and iron supplements respectively. This is a clear indication that women are not supplied with IFAs in every ANC appointment as recommended by MIYCN.
Stock shortage was the major challenge that affected frequency of supplementation as mentioned by a programme implementer:
“Sometimes like now we have very few pills in the drug store and I don’t foresee the possibility of receiving the stock any time soon. In such circumstance, we prioritise those women whose HB is low. Others we give them half of the required dose at least to ensure equitable distribution.” (nursing officer in charge of MCH)
This was confirmed by one of the intervention recipients:
“They checked my blood (HB) and they found it was sufficient so I wasn’t given any drugs (supplements).” (R24)
Other facilities did not have any stock at all:
“We have run short of stock for the past three months. It is more than four months now ever since we placed the order. In this case we prescribe supplements to the women and advise them to buy from the drug stores in the market………..With the County government, procurement process takes too long.” (Nursing officer in charge of a health facility)
Moderating factors
The moderating factors assessed in this study relate to quality of delivery and participant responsiveness to the intervention. Various indicators were assessed as presented in Table 3.
Table 3: Participant responsiveness and quality of delivery
|
Characteristics of women
|
Distribution (n)
|
Percentage (%)
|
Mean
|
|
Coverage of interventions
|
Did not access any ANC
|
2
|
1
|
|
Accessed health ANC
|
186
|
99
|
|
|
Initial access to interventions
|
Gestational age at first ANC visit (weeks) (n=186)
|
|
|
|
<13 weeks
|
18
|
10
|
|
13-19.9
|
27
|
14
|
|
20-26.9
|
95
|
51
|
|
≥27
|
46
|
25
|
|
Average
|
|
|
23.4 weeks
|
|
Frequency of access to ANC services (based on RDM )
Number of times (n=86)
|
Number of times (n=86)
|
|
|
|
1
|
4
|
5
|
|
2
|
14
|
16
|
|
3
|
30
|
35
|
|
4
|
22
|
26
|
|
≥5
|
16
|
19
|
|
|
Adherence to the supplements issued in prior ANC visits
|
Finished iron supplements
|
94
|
68
|
|
Finished folic acid
|
56
|
64
|
|
|
|
|
|
|
|
|
|
|
Reasons for non-adherence to supplements
|
Iron (n=44)
|
Side effects
|
25
|
57
|
|
Delivered before finishing
|
8
|
18
|
|
Drugs were too many
|
6
|
14
|
|
Haemoglobin was okay
|
3
|
7
|
|
Confusing dose
|
1
|
2
|
|
Was using traditional herbs
|
1
|
2
|
|
Folic Acid (n=32)
|
|
|
|
Side effects
|
19
|
59
|
|
Delivered before finishing
|
5
|
16
|
|
Haemoglobin was good
|
3
|
10
|
|
Drugs were too many
|
2
|
6
|
|
Made her sleep a lot
|
1
|
3
|
|
Forgetful
|
1
|
3
|
|
She stopped vomiting
|
1
|
3
|
|
|
Motivations for adherence to supplements
|
Iron (n=94)
|
Its usefulness
|
43
|
46
|
|
Obeyed doctor’s instructions
|
30
|
32
|
|
Was sick
|
12
|
13
|
|
Did not experience side effects
|
9
|
9
|
|
Folic Acid (n=56)
|
|
|
|
Its usefulness
|
24
|
43
|
|
Obeyed doctor’s instructions
|
20
|
36
|
|
Was sick
|
8
|
14
|
|
Did not experience side effects
|
4
|
7
|
|
|
Knowledge on Iron supplementation (uses) (n=138)
|
Increases amount of blood of the mother
|
110
|
80
|
|
I don’t know
|
19
|
13
|
|
Eliminates the urge of eating soil
|
5
|
4
|
|
Development of the baby
|
4
|
3
|
|
|
Knowledge on Folic Acid supplementation (uses) (n=88)
|
I don’t know
|
36
|
40
|
|
Development of the baby
|
19
|
22
|
|
Bone formation and strengthening
|
6
|
7
|
|
Increases mother’s amount of blood
|
5
|
6
|
|
Improves mother’s appetite
|
4
|
5
|
|
Prevents the baby from developing deformities
|
4
|
5
|
|
Multivitamins
|
3
|
3
|
|
Gives energy to mother
|
3
|
3
|
|
Anti-malaria
|
2
|
2
|
|
Immunity booster
|
2
|
2
|
|
Reduces heartburns
|
2
|
2
|
|
Spine formation of the baby
|
2
|
2
|
|
Prevents vomiting and nausea feelings
|
1
|
1
|
|
|
Sources of general nutrition knowledge (n=188)
|
own knowledge
|
69
|
37
|
|
Other women
|
31
|
16.5
|
|
Health officer
|
30
|
16
|
|
Learned in school
|
21
|
11
|
|
Experiences from previous pregnancy
|
13
|
7
|
|
Self and hospital
|
11
|
6
|
|
School and hospital
|
7
|
4
|
|
Other women and hospital
|
5
|
2
|
|
Radio
|
1
|
0.5
|
|
|
Dosage prescribed Ferrous Iron (n=138)
|
one pill daily
|
83
|
60
|
|
one pill three times a day
|
28
|
20
|
|
one pill twice a day
|
17
|
12
|
|
two pills once a day
|
6
|
4
|
|
two pills three times a day
|
4
|
3
|
|
|
Dosage prescription Folic acid (n=88)
|
one pill daily
|
57
|
65
|
|
one pill twice a day
|
15
|
17
|
|
one pill three times a day
|
12
|
14
|
|
two pills three times a day
|
4
|
4
|
|
|
Quality of delivery
For those who were supplied with supplements, the dosage prescribed to them varied considerably. Correct dosage of one supplement daily was reported by 83% and 57% of the respondents for Iron and FA respectively as indicated in Table 3. One of the programme implementers clarified the differences in dosage in iron supplementation:
“…. If the tested HB status reads below 10 g/dl, we give a prescription of one pill three times a day, after one month we re- test HB, if it has improved, we reduce the dose to one pill daily for the remaining months until birth” (Nursing officer at a health facility)
On the other hand, one programme implementer felt that too many drugs are not healthy to a pregnancy:
“You know these are chemicals: too much chemicals are not healthy to human bodies especially when pregnant. When a woman’s HB is more than 13g/dl I don’t see the need of pumping her with chemicals so in that case I don’t issue the supplements.” (Nursing officer working in MCH at a hospital)
Shortage of pills not only affected adherence but also quality of delivery by the health providers.
Participant responsiveness to the intervention
We investigated the degree to which pregnant women embraced the interventions and this was measured by access to interventions, adherence to the intervention instructions and their understanding of the interventions.
Access to interventions: According to the MYICN guidelines, interventions should be initiated around the time of conception to increase their efficacy. Each woman is also expected to make at least four ANC appointments during the entire period of pregnancy. In this study, as indicated in Table 3 it was established that out of 186 women who availed for ANC services only 10% initiated contact with the ANC within the first trimester and only 45% made four or more appointments during the entire period of pregnancy (based on the recently delivered women).
Adherence to the intervention: According to the self-reported adherence, 68% and 64% of the respondents finished the pills issued for iron and folic acid supplements respectively during the previous appointments. Usefulness of the supplements (46% and 43% respectively) and obedience to the doctor’s instructions (36% and 32% respectively) were the major motivating factors to complete the dose.
“I know during birth a woman loses a lot of blood. I had to finish taking them because I wanted to be on a safer side by having enough blood back-up.” (R9)
“During my last birth, I underwent an operation and lost a lot of blood. I really had to finish the pills to ensure I have enough blood back-up for the next birth.” (R30)
“Actually, I don’t know its usefulness. Because it is issued by a learned informed doctor, I believed it must have some importance to a pregnancy so I decided to finish taking them.” (R19)
On the other hand, anticipated and experienced side effects were the major reason reported by more than 50% of the respondents for non-adherence.
“It leaves a bad lasting annoying smell in the throat when you take them. I just don’t like taking them.” (R7)
“My HB status was good so I did not bother taking them. You know how they are bad.” (R18)
Others respondents gave other reasons, such as use of other (traditional) drugs:
“I was already taking other drugs that I was given to prevent miscarriage. So I felt that the drugs have become too many and I decided to stop taking the supplements I first finish the previous drugs which I felt were more important.” (R1)
“My husband had bought for me herbal medicine. I decided not to mix taking both. I decided to finish the herbs first then I continue with the hospital pills.” (R26)
Or the perceived high number of pills:
“I did not finish them; they were too many. I gave birth but still many were left over.” (R20)
Another reason for poor adherence resulted from confusion about the dosage variation, which was not explained by the health worker. One pregnant respondent reported that:
“The first time when I came for ANC services the nurse gave me 30 pills and told me to take one pill per day. The second time I got a different nurse. She gave me so many pills and advised me to take one three times a day. I now got confused. I decided to follow the previous dose prescription. That is why you can see I still have so many unfinished pills.” (R2)
Other motivational and demotivating reasons for adherence to the supplements are presented in Table 3.
Understanding of the intervention. A large majority of the respondents (80%) had correct knowledge on the importance of consumption of iron supplements, unlike folic acid supplementation where 40% of the respondents did not understand the importance of taking it. Mixed responses from intervention recipients on the importance of taking folic acid emerged as presented in Table 3.
“I know it helps in the development of the baby but I don’t know how.” (R66)
“It helps to relief heartburns. When I was taking them, it relieved my heartburns so I continued taking them.” (R171)
“It helps one to sleep. I used to sleep a lot and that is why I stopped taking them.” (R146)
“It reduces that urge of wanting to eat soil (pica).” (R170)
“It prevents malaria.” (R151)
On the other hand, multiple sources of nutritional knowledge were reported by the respondents and this is likely to compete with hospital knowledge and may affect adherence. Only 16% of the interviewed respondents reported to rely on the knowledge acquired at the hospital. The highest number of the respondents rely on own-knowledge (37%) and the knowledge acquired either from other women relations (16%) or from school (11%) and others combined knowledge acquired from the several sources.